Review



fitc conjugated mouse anti human cd63  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bio-Rad fitc conjugated mouse anti human cd63
    Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or <t>anti-CD63</t> (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and <t>CD63</t> is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Fitc Conjugated Mouse Anti Human Cd63, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc conjugated mouse anti human cd63/product/Bio-Rad
    Average 93 stars, based on 31 article reviews
    fitc conjugated mouse anti human cd63 - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Immunofluorescence analysis of human eosinophils."

    Article Title: Immunofluorescence analysis of human eosinophils.

    Journal: Journal of immunological methods

    doi: 10.1016/j.jim.2024.113619

    Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or anti-CD63 (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and CD63 is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Figure Legend Snippet: Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or anti-CD63 (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and CD63 is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Techniques Used: Staining, Software

    Fig. 4. Object-based colocalization of IL-13þ and CD63þ granules in human eosinophils. Within 2 μm of the cell volumes, intracellular IL-13+ and CD63+
    Figure Legend Snippet: Fig. 4. Object-based colocalization of IL-13þ and CD63þ granules in human eosinophils. Within 2 μm of the cell volumes, intracellular IL-13+ and CD63+

    Techniques Used:



    Similar Products

    95
    Miltenyi Biotec (fitc)-conjugated anti cd63 (miltenyi, gladbach, germany)
    (Fitc) Conjugated Anti Cd63 (Miltenyi, Gladbach, Germany), supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/(fitc)-conjugated anti cd63 (miltenyi, gladbach, germany)/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    (fitc)-conjugated anti cd63 (miltenyi, gladbach, germany) - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Becton Dickinson fitc-conjugated mouse anti-human cd63 antibody
    Fitc Conjugated Mouse Anti Human Cd63 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc-conjugated mouse anti-human cd63 antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    fitc-conjugated mouse anti-human cd63 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Bio-Rad fitc conjugated mouse anti human cd63
    Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or <t>anti-CD63</t> (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and <t>CD63</t> is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Fitc Conjugated Mouse Anti Human Cd63, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc conjugated mouse anti human cd63/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    fitc conjugated mouse anti human cd63 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd63 conjugated fitc
    Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or <t>anti-CD63</t> (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and <t>CD63</t> is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Anti Cd63 Conjugated Fitc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd63 conjugated fitc/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-cd63 conjugated fitc - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti–human fitc–conjugated anti-cd63 (catalog 550759)
    ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and <t>CD63</t> by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Mouse Anti–Human Fitc–Conjugated Anti Cd63 (Catalog 550759), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti–human fitc–conjugated anti-cd63 (catalog 550759)/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    mouse anti–human fitc–conjugated anti-cd63 (catalog 550759) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher fitc-conjugated anti-human cd63 antibody
    ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and <t>CD63</t> by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Fitc Conjugated Anti Human Cd63 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc-conjugated anti-human cd63 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    fitc-conjugated anti-human cd63 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd63 fitc-conjugated antibody
    ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and <t>CD63</t> by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Anti Cd63 Fitc Conjugated Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd63 fitc-conjugated antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-cd63 fitc-conjugated antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Immunostep anti-cd63 fitc-conjugated tea3/18
    ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and <t>CD63</t> by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).
    Anti Cd63 Fitc Conjugated Tea3/18, supplied by Immunostep, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd63 fitc-conjugated tea3/18/product/Immunostep
    Average 90 stars, based on 1 article reviews
    anti-cd63 fitc-conjugated tea3/18 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or anti-CD63 (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and CD63 is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Journal of immunological methods

    Article Title: Immunofluorescence analysis of human eosinophils.

    doi: 10.1016/j.jim.2024.113619

    Figure Lengend Snippet: Fig. 3. Colocalization of IL-9 with TfnRcþ recycling endosomes and IL-13 with CD63þ crystalloid granules in PAF-stimulated eosinophils. Human eo sinophils were adhered to glass coverslips were stimulated with PAF for 5 and 60 min. Following fixation and permeabilization, cells were labelled with anti-IL-9 or anti-IL-13 (red) and anti-TfnRc for recycling endosomes or anti-CD63 (green) for crystalloid granules. Nuclei were stained with DAPI (blue). Merged images are shown at right with yellow regions (surface rendered with Imaris software) indicative of colocalization between intracellular cytokines and crystalloid granules. An unstimulated cell stained with IL-13 and CD63 is depicted on the left to showcase morphology. Data is from representative donor. Scale bar represents 5 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: Crystalloid granules were immunolabelled using FITC-conjugated mouse anti-human CD63 (Bio-Rad, Hercules, CA) with FITCconjugated mouse IgG1 isotype control (Bio-Rad).

    Techniques: Staining, Software

    Fig. 4. Object-based colocalization of IL-13þ and CD63þ granules in human eosinophils. Within 2 μm of the cell volumes, intracellular IL-13+ and CD63+

    Journal: Journal of immunological methods

    Article Title: Immunofluorescence analysis of human eosinophils.

    doi: 10.1016/j.jim.2024.113619

    Figure Lengend Snippet: Fig. 4. Object-based colocalization of IL-13þ and CD63þ granules in human eosinophils. Within 2 μm of the cell volumes, intracellular IL-13+ and CD63+

    Article Snippet: Crystalloid granules were immunolabelled using FITC-conjugated mouse anti-human CD63 (Bio-Rad, Hercules, CA) with FITCconjugated mouse IgG1 isotype control (Bio-Rad).

    Techniques:

    ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).

    Journal: JCI Insight

    Article Title: Sialylation regulates neutrophil transepithelial migration, CD11b/CD18 activation, and intestinal mucosal inflammatory function

    doi: 10.1172/jci.insight.167151

    Figure Lengend Snippet: ( A and B ) Human PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C, followed by stimulation with 1.25 μM LaB and 5 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 4–6 PMN donors, *** P < 0.001, **** P < 0.0001). ( C and D ) Murine PMN were exposed to 5 mM Sia, 5 mM Gal, 5 mM 2-DN, or 5 mM KDO for 30 minutes at 37°C followed by stimulation with 1.25 μM LaB and 10 μM fMLF to induce degranulation before assessment of surface expression of CD66b and CD63 by flow cytometry. Data shown are fold-change in mean fluorescence intensity (MFI) comparing treatment with sialidase inhibitors against relevant control (Gal or KDO). Data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing for PMN isolated from 3–5 mice (** P < 0.01, *** P < 0.001). ( E ) Human PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 500 nM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0, are expressed as mean ± SEM, and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 independent human PMN donors, * P < 0.05, ** P < 0.01, *** P < 0.001). ( F ) Murine PMN incubated with 5 mM Gal, 5 mM Sia, 5 mM 2-DN, or 5 mM KDO were exposed to 100 μM cytochrome C. Reduction of cytochrome C in response to 1 μM fMLF was measured by quantifying changes in absorbance at 550 nm at 2, 5, 10, 15, 20, and 60 minutes. Data are fold change in absorbance relative to time 0; data are expressed as mean ± SEM and were analyzed by 1-way ANOVA followed by Bonferroni post hoc testing ( n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001).

    Article Snippet: Mouse anti–human FITC–conjugated anti-CD63 (catalog 550759) and anti-CD66b (catalog 561927) mAbs were purchased from BD Bioscience Rat anti–mouse PE-conjugated CD63 (catalog 12063182) and anti-CD15 (catalog MA1-022) mAbs were purchased from Thermo Fisher Scientific.

    Techniques: Expressing, Flow Cytometry, Fluorescence, Isolation, Incubation